AU2003286692A1 - Modulation of dendritic cell function and other cellular responses mediated by defensin compositions - Google Patents

Modulation of dendritic cell function and other cellular responses mediated by defensin compositions

Info

Publication number
AU2003286692A1
AU2003286692A1 AU2003286692A AU2003286692A AU2003286692A1 AU 2003286692 A1 AU2003286692 A1 AU 2003286692A1 AU 2003286692 A AU2003286692 A AU 2003286692A AU 2003286692 A AU2003286692 A AU 2003286692A AU 2003286692 A1 AU2003286692 A1 AU 2003286692A1
Authority
AU
Australia
Prior art keywords
defensin
modulation
compositions
dendritic cell
cell function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003286692A
Other versions
AU2003286692A8 (en
Inventor
Arya Biragyn
Larry W. Kwak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2003286692A8 publication Critical patent/AU2003286692A8/en
Publication of AU2003286692A1 publication Critical patent/AU2003286692A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2003286692A 2002-10-25 2003-10-24 Modulation of dendritic cell function and other cellular responses mediated by defensin compositions Abandoned AU2003286692A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42148802P 2002-10-25 2002-10-25
US60/421,488 2002-10-25
PCT/US2003/033940 WO2004038002A2 (en) 2002-10-25 2003-10-24 Modulation of dendritic cell function and other cellular responses mediated by defensin compositions

Publications (2)

Publication Number Publication Date
AU2003286692A8 AU2003286692A8 (en) 2004-05-13
AU2003286692A1 true AU2003286692A1 (en) 2004-05-13

Family

ID=32176721

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003286692A Abandoned AU2003286692A1 (en) 2002-10-25 2003-10-24 Modulation of dendritic cell function and other cellular responses mediated by defensin compositions

Country Status (2)

Country Link
AU (1) AU2003286692A1 (en)
WO (1) WO2004038002A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080286312A1 (en) * 2002-06-12 2008-11-20 Gavish-Galilee Bio Applications Ltd. Membrane-anchored beta2 microglobulincovalently linked to MHC class I peptide epitopes
MA44334A (en) 2015-10-29 2018-09-05 Novartis Ag ANTIBODY CONJUGATES INCLUDING A TOLL-TYPE RECEPTOR AGONIST

Also Published As

Publication number Publication date
AU2003286692A8 (en) 2004-05-13
WO2004038002A2 (en) 2004-05-06
WO2004038002A3 (en) 2005-01-27

Similar Documents

Publication Publication Date Title
AU2003253897A1 (en) Dendritic cell pontentiation
AU2002318944A1 (en) Methods and compositions relating to plasmacytoid dendritic cells
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2003225530A1 (en) Solid polymer electrolyte and method of preparation
AU2003244417A1 (en) Cellular mosfet devices and their manufacture
AU2003219484A1 (en) Classification of cellular network drive test results
AU2003207798A1 (en) Degradable crosslinkers, and degradable crosslinked hydrogels comprising them
AU2003299441A1 (en) Nf-hev compositions and methods of use
AU2003228205A1 (en) Porous polymers: compositions and uses thereof
AU2003210899A1 (en) Adhesive compositions and tapes comprising same
AU2003247351A1 (en) Anti-acne compositions and methods of use
AU2003213120A1 (en) Human rnase iii and compositions and uses thereof
AU2003216840A1 (en) Transdifferentiation of cells and tissues
AU2003239579A1 (en) Antisense modulation of vegf-c expression
AU2003237416A1 (en) Novel tolerogenic dendritic cells and therapeutic uses therefor
AU2003220343A1 (en) Compositions of pentafluoropropane
AU2003240281A1 (en) Cell targeting methods and compositions
AU2003286692A1 (en) Modulation of dendritic cell function and other cellular responses mediated by defensin compositions
AU2002316552A1 (en) Inhibitor of t cell activation
AU2003286312A1 (en) Method and mobile terminal arrangement for fast switching between multiple peripherals
AU2003253780A1 (en) TCELL TOLERANCE AND MODULATION OF AUTOIMMUNITY BY CD8Alpha-CD4+ DENDRITIC CELLS
AU2003901205A0 (en) Therapeutic and prophylactic compositions and uses therefor
AU2001274815A1 (en) Compositions and methods for inducing activation of dendritic cells
AU2003268078A1 (en) Levothyroxine compositions and methods
AU2003262932A1 (en) Silicone based compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase